|
| Entrez Id: |
1243 |
| Gene Symbol: |
CMM |
CMM
|
|
cutaneous malignant melanoma/dysplastic nevus
|
|
37
|
0.670 |
0.385 |
|
0.060 |
None
|
0.833 |
6
|
0
|
1983 |
2017 |
|
| Entrez Id: |
115482713 |
| Gene Symbol: |
H3P10 |
H3P10
|
|
H3 histone pseudogene 10
|
|
769
|
0.350 |
0.846 |
|
0.040 |
None
|
1.000 |
4
|
0
|
1995 |
2006 |
|
| Entrez Id: |
406991 |
| Gene Symbol: |
MIR21 |
MIR21
|
|
microRNA 21
|
|
726
|
0.363 |
0.846 |
|
0.040 |
None
|
1.000 |
4
|
0
|
2012 |
2016 |
|
| Entrez Id: |
4513 |
| Gene Symbol: |
COX2 |
COX2
|
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
875
|
0.352 |
0.962 |
|
0.040 |
None
|
1.000 |
4
|
0
|
1999 |
2019 |
|
| Entrez Id: |
107075310 |
| Gene Symbol: |
MTCO2P12 |
MTCO2P12
|
|
MT-CO2 pseudogene 12
|
|
703
|
0.368 |
0.962 |
|
0.030 |
None
|
1.000 |
3
|
0
|
1999 |
2009 |
|
LOC110806263
|
|
TERT 5' regulatory region
|
|
245
|
0.464 |
0.731 |
|
0.030 |
None
|
1.000 |
3
|
0
|
2013 |
2015 |
|
LINC01505
|
|
long intergenic non-protein coding RNA 1505
|
|
16
|
0.821 |
0.192 |
|
0.100 |
None
|
1.000 |
2
|
2
|
2015 |
2018 |
|
| Entrez Id: |
3342 |
| Gene Symbol: |
HTC2 |
HTC2
|
|
hypertrichosis 2 (generalized, congenital)
|
|
511
|
0.392 |
0.808 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2010 |
2013 |
|
| Entrez Id: |
3439 |
| Gene Symbol: |
IFNA1 |
IFNA1
|
P01562
|
interferon alpha 1
|
|
662
|
0.371 |
0.923 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2017 |
2017 |
|
| Entrez Id: |
3447 |
| Gene Symbol: |
IFNA13 |
IFNA13
|
P01562
|
interferon alpha 13
|
|
646
|
0.374 |
0.923 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2017 |
2017 |
|
| Entrez Id: |
407006 |
| Gene Symbol: |
MIR221 |
MIR221
|
|
microRNA 221
|
|
304
|
0.449 |
0.846 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2009 |
2014 |
|
| Entrez Id: |
80316 |
| Gene Symbol: |
PPP1R2C |
PPP1R2C
|
O14990
|
PPP1R2C family member C
|
Enzyme modulator
|
231
|
0.478 |
0.846 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2011 |
2017 |
|
| Entrez Id: |
100270680 |
| Gene Symbol: |
CASC11 |
CASC11
|
|
cancer susceptibility 11
|
|
45
|
0.641 |
0.577 |
|
0.100 |
None
|
1.000 |
1
|
3
|
2016 |
2016 |
|
| Entrez Id: |
100302234 |
| Gene Symbol: |
MIR664A |
MIR664A
|
|
microRNA 664a
|
|
43
|
0.644 |
0.538 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2015 |
2015 |
|
LINC00963
|
|
long intergenic non-protein coding RNA 963
|
|
28
|
0.700 |
0.269 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2018 |
2018 |
|
| Entrez Id: |
100616444 |
| Gene Symbol: |
ERVK-20 |
ERVK-20
|
|
endogenous retrovirus group K member 20
|
|
143
|
0.533 |
0.692 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
|
| Entrez Id: |
100775105 |
| Gene Symbol: |
ERVK-18 |
ERVK-18
|
|
endogenous retrovirus group K member 18
|
|
106
|
0.560 |
0.654 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
|
FOXD3-AS1
|
|
FOXD3 antisense RNA 1
|
|
18
|
0.743 |
0.192 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
|
| Entrez Id: |
10866 |
| Gene Symbol: |
HCP5 |
HCP5
|
Q6MZN7
|
HLA complex P5
|
|
79
|
0.595 |
0.808 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
|
| Entrez Id: |
110006328 |
| Gene Symbol: |
ERVK-32 |
ERVK-32
|
|
endogenous retrovirus group K member 32, envelope
|
|
158
|
0.522 |
0.692 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
|
| Entrez Id: |
115482684 |
| Gene Symbol: |
H3P9 |
H3P9
|
|
H3 histone pseudogene 9
|
|
177
|
0.505 |
0.731 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2005 |
2005 |
|
| Entrez Id: |
144203 |
| Gene Symbol: |
OVOS2 |
OVOS2
|
|
alpha-2-macroglobulin like 1 pseudogene
|
|
3
|
1.000 |
0.077 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2018 |
2018 |
|
| Entrez Id: |
1485 |
| Gene Symbol: |
CTAG1B |
CTAG1B
|
P78358
|
cancer/testis antigen 1B
|
|
166
|
0.507 |
0.731 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2020 |
2020 |
|
LINC00032
|
P0C843
|
long intergenic non-protein coding RNA 32
|
Enzyme
|
9
|
0.839 |
0.077 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2007 |
2007 |
|
| Entrez Id: |
158376 |
| Gene Symbol: |
SPAAR |
SPAAR
|
A0A1B0GVQ0
|
small regulatory polypeptide of amino acid response
|
|
28
|
0.711 |
0.385 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |